# SGLT2 Inhibitors and Cognitive Function in Adults With Type 2 Diabetes (SaveMinD)

> **NCT07694596** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University of Primorska** · enrollment: 200 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus (T2DM)
- Cognitive Dysfunction

## Interventions

- **DRUG:** SGLT2 Inhibitor
- **OTHER:** Standard Diabetes Care

## Key facts

- **NCT ID:** NCT07694596
- **Lead sponsor:** University of Primorska
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-06-20
- **Primary completion:** 2028-04-20
- **Final completion:** 2028-04-20
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-07-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07694596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07694596, "SGLT2 Inhibitors and Cognitive Function in Adults With Type 2 Diabetes (SaveMinD)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07694596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*